Characteristics of Initiators of Different Osteoporosis (OP) Medications among Women with Postmenopausal Osteoporosis (PMO) in The Health Improvement Network (THIN) in the UK

Oct-12

Gynecology and Obstetrics Musculoskeletal Pharmacoepidemiology Women's Health

AUTHORS : Fei Xue, Center for Observational Research, Amgen Inc., One Amgen Center Drive, MS 24-2-C, Thousand Oaks, CA 91320, USA – Email: fxue@amgen.com

JOURNAL : Journal of Bone and Mineral Research

REFERENCE: 27(S1):S321-S322

DOI : 10.1002/jbmr.1852

Characteristics of Initiators of Different Osteoporosis (OP) Medications among Women with Postmenopausal Osteoporosis (PMO) in The Health Improvement Network (THIN) in the UK

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study